Showing 1 - 20 results of 11,004 for search '(( 5 ((nn decrease) OR (026 decrease)) ) OR ((( 50 c decrease ) OR ( 5 mm decrease ))))', query time: 0.43s Refine Results
  1. 1
  2. 2

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
  3. 3
  4. 4

    Funnel plot. by Junyin Pan (20700411)

    Published 2025
    Subjects:
  5. 5

    Forest plot. by Junyin Pan (20700411)

    Published 2025
    Subjects:
  6. 6
  7. 7
  8. 8

    S2 File - by Junyin Pan (20700411)

    Published 2025
    Subjects:
  9. 9
  10. 10
  11. 11

    Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis by Ying Yang (24175)

    Published 2019
    “…In contrast, 50 μM SKPin C1 only marginally decreased viability of normal B lymphocytes in 12 h. …”
  12. 12
  13. 13
  14. 14
  15. 15

    Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

    Published 2025
    “…<b>C</b>. Representative traces of TEA-sensitive potassium currents (1mM). …”
  16. 16

    Etesevimab in combination with JS026 neutralizing SARS-CoV-2 and its variants by Fengze Wang (10452968)

    Published 2022
    “…A cocktail of etesevimab and JS026 increased neutralizing efficacy against both wild-type SARS-CoV-2 and the recent emergence of Alpha, Beta, Gamma, and Delta variants. …”
  17. 17
  18. 18
  19. 19
  20. 20